Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the launch of its direct to consumer television advertising campaign.
“The campaign aims to reduce the stigma associated with these conditions, raise awareness of the Axonics brand and therapies, and encourage women to consult a bladder specialist.”
The Find Real Relief campaign is focused on women with any form of urinary incontinence, a large and significantly undertreated population. The campaign aims to reduce the stigma associated with these conditions, raise awareness of the Axonics brand and therapies, and encourage women to consult a bladder specialist.
The advertisements feature women with urinary incontinence that have been treated with Axonics sacral neuromodulation (SNM) therapy after consulting with their physician. The women speak authentically about the challenges of living with incontinence and how Axonics has provided them life-changing symptom relief.
The advertisements encourage viewers to visit FindRealRelief.com, Axonics’ new patient-facing landing page. This website provides information about Axonics’ incontinence solutions and directs interested individuals to complete a short symptom quiz. Qualified individuals will then be contacted by a team of nurses in an effort to connect the person to a specialist physician in their community.
The advertisements are now airing on television in over 40 markets across the United States and are scheduled to run through the end of the year. During the month of May, the advertisements will be featured on national television during programs that rate highly with the target demographic. The Find Real Relief campaign will also include targeted advertising on YouTube, Facebook, digital audio, and various websites.
“Tens of millions of Americans suffer from urinary incontinence and struggle to find long-term symptom relief,” said John Woock, Ph.D., executive vice president, chief marketing and strategy officer of Axonics. “The company is making this significant investment because we are committed to this patient population and it is important that Americans suffering from incontinence have the opportunity to find relief for their symptoms. Our omnichannel strategy will establish the Axonics brand and allow us to engage adults with incontinence across multiple platforms with a consistent message that new, life-changing incontinence therapies are available to them. We are excited to launch this television advertising campaign and we are confident that it will continue to drive SNM market expansion and advance Axonics on its path to market leadership.”
Comments are closed.